Histone deacetylase (HDAC) inhibitors used in clinical trials arranged... | Download Scientific Diagram
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
Current HDAC Inhibitor Clinical Trials for Patients With Melanoma or... | Download Table
HDAC inhibitors clinical status. The clinical trials information was... | Download Scientific Diagram
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma | PNAS
Cancers | Free Full-Text | HDAC Inhibition to Prime Immune Checkpoint Inhibitors | HTML
Hydroxamic acid based HDAC inhibitors in clinical trials. | Download Table
Frontiers | Recent Update of HDAC Inhibitors in Lymphoma | Cell and Developmental Biology
HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
FDA approved and selected ongoing clinical trials involving HDAC... | Download Scientific Diagram
HDAC Inhibitors in Clinical Trials | Download Table
IJMS | Free Full-Text | Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases | HTML
Overview of selected clinical trials for combination of HMAs and HDAC... | Download Table
HDAC inhibitors currently under clinical investigation. Various HDAC... | Download Scientific Diagram
Histone deacetylase inhibitors: molecular mechanisms of action | Oncogene
Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials - Journal of Thoracic Oncology
HDAC Inhibition | HDAC Inhibitor Review & List
Characteristics of HDAC inhibitors in clinical trials. | Download Table
New HDAC inhibitors in clinical trials | Download Table
IJMS | Free Full-Text | HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases | HTML
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs | EMBO Molecular Medicine
Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer - eBioMedicine
IJMS | Free Full-Text | Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia | HTML
Frontiers | Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma | Cell and Developmental Biology
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
Achieving clinical success with BET inhibitors as anti-cancer agents | British Journal of Cancer
Histone deacetylase inhibitors (HDACi) that are currently approved by... | Download Scientific Diagram
HDAC Inhibitors in the clinical trials. | Download Scientific Diagram
